Panacea Biotech enters into pact with Kremers Urban; stock up
Economic Times
The company will also launch Tacrolimus Capsules, the first product in this portfolio, in the US in November 2012. The drug is used along with other medications to prevent rejection (attack of a transplanted organ by the immune system of a person ...
Panacea Biotec Allies With Kremers Urban: To Launch Tacrolimus Capsules In USRTT News
Panacea Biotec partners Kremers Urban for US marketingBusiness Standard
Panacea Biotec surges 4% on tie-up with Kremers

all 11 news articles »